|
USPL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.067700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.719800E-02 |
| Normal-vs-Stage2 |
1.653780E-01 |
| Normal-vs-Stage3 |
4.757600E-01 |
| Normal-vs-Stage4 |
9.048000E-01 |
| Stage1-vs-Stage2 |
4.599200E-01 |
| Stage1-vs-Stage3 |
5.720400E-02 |
| Stage1-vs-Stage4 |
3.785400E-01 |
| Stage2-vs-Stage3 |
9.994000E-02 |
| Stage2-vs-Stage4 |
1.877160E-01 |
| Stage3-vs-Stage4 |
7.039600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.179500E-02 |
| Normal-vs-AfricanAmerican |
1.542950E-01 |
| Normal-vs-Asian |
2.040800E-01 |
| Caucasian-vs-AfricanAmerican |
8.425000E-01 |
| Caucasian-vs-Asian |
6.402300E-04 |
| AfricanAmerican-vs-Asian |
3.936900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.403500E-03 |
| Normal-vs-Female |
5.454200E-01 |
| Male-vs-Female |
8.418300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.703200E-01 |
| Normal-vs-Extreme_Weight |
8.639700E-02 |
| Normal-vs-Obese |
7.250300E-02 |
| Normal-vs-Extreme_Obese |
9.189400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.063400E-01 |
| Normal_Weight-vs-Obese |
3.144800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.001000E-01 |
| Extreme_Weight-vs-Obese |
7.440800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.555800E-01 |
| Obese-vs-Extreme_Obese |
4.096800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.470200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.777290E-03 |
| Normal-vs-Age(61-80Yrs) |
1.775950E-01 |
| Normal-vs-Age(81-100Yrs) |
8.376200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.643420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.226800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.593200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.426100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.137600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.185600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.6292999999965E-05 |
| Normal-VS-Type2 PRCC |
2.806400E-02 |
| Normal-VS-KIRP CIMP |
1.524950E-03 |
| Normal-VS-Unclassified PRCC |
1.501640E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.20330437123084E-13 |
| Type1 PRCC-VS-KIRP CIMP |
1.72480000282249E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
4.138600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.113980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.116700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.248300E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.663600E-01 |
| Normal-vs-N1 |
7.356800E-01 |
| Normal-vs-N2 |
2.579600E-02 |
| N0-vs-N1 |
6.847800E-01 |
| N0-vs-N2 |
1.356430E-01 |
| N1-vs-N2 |
1.428410E-01 |
|
|
